In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Vigabatrin Aventis Brand Drug Master File in Korea (Vigabatrin Aventis Brand KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Vigabatrin Aventis Brand. The MFDS reviews the Vigabatrin Aventis Brand KDMF as part of the drug registration process and uses the information provided in the Vigabatrin Aventis Brand KDMF to evaluate the safety and efficacy of the drug.
After submitting a Vigabatrin Aventis Brand KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Vigabatrin Aventis Brand API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Vigabatrin Aventis Brand suppliers with KDMF on PharmaCompass.